Kiromic Biopharma, Inc. (KRBP) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Revenues			0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold			0.0	0.0	0.0	0.0	0.0	0.0
Gross profit			0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]			20.5	18.5	16.3	13.9	9.1	7.6
General and administrative			20.5	18.5	16.3	13.9	9.1	7.6
Research and development			13.9	13.6	12.4	11.4	9.6	7.3
EBITDA [+]			-33.2	-31.3	-28.2	-24.8	-18.2	-14.6
EBITDA growth			82.1%	115.0%	33.8%	30.7%	3.1%	-9.8%
Depreciation			1.3	0.8	0.6	0.5	0.4	0.3
EBITA			-34.4	-32.2	-28.7	-25.3	-18.6	-14.9
Amortization of intangibles						0.0	0.0
EBIT [+]			-34.4	-32.2	-28.7	-25.3	-18.6	-14.9
EBIT growth			84.8%	115.8%	34.8%	31.8%	4.6%	-8.4%
Non-recurring items						0.4
Interest expense			0.0			0.0	0.0	0.0
Interest expense			0.0			0.0	0.0	0.0
Other income (expense), net [+]			-3.4	0.0	0.1	0.2	0.1
Litigation settlement			-3.5
Other non-operating income						0.1	0.0
Other						-0.1	0.0
Pre-tax income			-38.3	-32.6	-29.1	-25.6	-18.5	-14.8
Income taxes			0.0	0.0	0.0	0.0	0.0	0.0
Tax rate			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income			-38.3	-32.6	-29.1	-25.6	-18.5	-14.8

Basic EPS [+]			($5.41)	($4.68)	($3.36)	($2.47)	($2.14)	($2.45)
Growth			152.5%	91.0%	-21.1%	-50.4%	-58.5%	-56.1%
Diluted EPS [+]			($5.41)	($4.68)	($3.36)	($2.47)	($2.14)	($2.45)
Growth			152.5%	91.0%	-21.1%	-50.4%	-58.5%	-56.1%


Shares outstanding (basic) [+]			7.1	7.0	8.7	10.4	8.6	6.0
Growth			-18.1%	15.1%	74.1%	168.6%	150.5%	107.2%
Shares outstanding (diluted) [+]			7.1	7.0	8.7	10.4	8.6	6.0
Growth			-18.1%	15.1%	74.1%	168.6%	150.5%	107.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.